Read + Share
Amedeo Smart
Independent Medical Education
Maurer M, Ensina LF, Gimenez-Arnau AM, Sussman G, et al. Efficacy and safety of ligelizumab in adults and adolescents with chronic spontaneous urticaria: results of two phase 3 randomised controlled trials. Lancet 2024;403:147-159.PMID: 38008109
Email
LinkedIn
Facebook
Twitter
Privacy Policy